Owkin

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Owkin is a French-American artificial intelligence and biotech company that builds agentic AI to analyze data, identify new treatments, optimize clinical trials and develop AI diagnostics. The company uses multimodal patient data from academic institutions and hospitals to train its AI models for data analysis, drug discovery, and drug development. Owkin collaborates with pharmaceutical companies around the world to improve their therapeutic programs.

Owkin is a French-American artificial intelligence and biotech company that builds agentic AI to analyze data, identify new treatments, optimize clinical trials and develop AI diagnostics. The company uses multimodal patient data from academic institutions and hospitals to train its AI models for data analysis, drug discovery, and drug development. Owkin collaborates with pharmaceutical companies around the world to improve their therapeutic programs. Courtiol, Pierre et al.

“Deep learning-based classification of mesothelioma improves prediction of patient outcome”, Nat Med 25, 1519–1525 (2019) Schmauch, Benoît et al. “A deep learning model to predict RNA-Seq expression of tumours from whole slide images”, Nature Communications volume 11, Article number: 3877 (2020) Jean Ogier du Terrail et al. “Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer" Nat Med (2023).

10.1038/s41591-022-02155 Saiilard et al., “Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma” Nat Commun 14, 3459 (2023) Saillard et al., “Validation of MSIntuit as an AI-based pre-screening tool for MSI detection from colorectal cancer histology slides” Nature Communications 14, 6695 (2023) Saillard et al., "Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides" Hepatology 72 (2020)

Text derived from https://en.wikipedia.org/w/index.php?oldid=1378870349 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

33 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.